Ole Andreas Halvorsen - Viking Global Investors 13F Activity & Position Changes (Q3 2022)
According to the SEC 13F filed on Nov 14, 2022, the Viking Global Investors portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2022, the filing reported:
New Buys - Apellis Pharmaceuticals, Inc., Alibaba Group Holding Limited, CBRE Group Inc, Cadence Design Systems, Inc., Clorox Company (The), and 14 more
Increases - Ameriprise Financial, Inc., Amazon.com, Inc., APi Group Corporation, Brookfield Asset Management Ltd., BioMarin Pharmaceutical Inc., and 22 more
Reductions - Acadia Healthcare Company, Inc., Amylyx Pharmaceuticals, Inc., Avantor, Inc., KE Holdings Inc, Chubb Limited, and 18 more
Complete Exits - American International Group, I, Aon Plc, Boeing Company (The), Booking Holdings Inc. Common St, Avis Budget Group, Inc., and 8 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2022
|
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-519,544
|
|
Q3 2022
|
AIG
American International Group, I
|
Sell - Position Exit |
-10,108,715
|
|
Q3 2022
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
Sell |
-1,400,000
|
|
Q3 2022
|
AMP
Ameriprise Financial, Inc.
|
Buy |
+620,093
|
|
Q3 2022
|
AMZN
Amazon.com, Inc.
|
Buy |
+1,182,054
|
|
Q3 2022
|
AON
Aon Plc
|
Sell - Position Exit |
-704,639
|
|
Q3 2022
|
APG
APi Group Corporation
|
Buy |
+184,754
|
|
Q3 2022
|
APLS
Apellis Pharmaceuticals, Inc.
|
Buy - Position Entry |
+932,441
|
|
Q3 2022
|
AVTR
Avantor, Inc.
|
Sell |
-3,270,023
|
|
Q3 2022
|
BA
Boeing Company (The)
|
Sell - Position Exit |
-1,391,238
|
|
Q3 2022
|
BABA
Alibaba Group Holding Limited
|
Buy - Position Entry |
+1,246,400
|
|
Q3 2022
|
BAM
Brookfield Asset Management Ltd.
|
Buy |
+2,625,832
|
|
Q3 2022
|
BEKE
KE Holdings Inc
|
Sell |
-6,515,507
|
|
Q3 2022
|
BKNG
Booking Holdings Inc. Common St
|
Sell - Position Exit |
-89,251
|
|
Q3 2022
|
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
+46,571
|
|
Q3 2022
|
BSX
Boston Scientific Corporation
|
Buy |
+1,508,967
|
|
Q3 2022
|
CAR
Avis Budget Group, Inc.
|
Sell - Position Exit |
-278,673
|
|
Q3 2022
|
CB
Chubb Limited
|
Sell |
-180,984
|
|
Q3 2022
|
CBRE
CBRE Group Inc
|
Buy - Position Entry |
+409,714
|
|
Q3 2022
|
CDNS
Cadence Design Systems, Inc.
|
Buy - Position Entry |
+605,539
|
|
Q3 2022
|
CLDX
Celldex Therapeutics, Inc.
|
Sell - Position Exit |
-2,337,854
|
|
Q3 2022
|
CLX
Clorox Company (The)
|
Buy - Position Entry |
+606,655
|
|
Q3 2022
|
CME
CME Group Inc.
|
Buy |
+322,471
|
|
Q3 2022
|
CNC
Centene Corporation
|
Sell - Position Exit |
-8,293,867
|
|
Q3 2022
|
CRL
Charles River Laboratories Inte
|
Buy |
+105,069
|
|
Q3 2022
|
CRM
Salesforce, Inc.
|
Buy - Position Entry |
+2,400,649
|
|
Q3 2022
|
CRWD
CrowdStrike Holdings, Inc.
|
Buy - Position Entry |
+284,329
|
|
Q3 2022
|
CTLT
Catalent, Inc.
|
Sell |
-287,494
|
|
Q3 2022
|
DAWN
Day One Biopharmaceuticals, Inc
|
Sell |
-298,861
|
|
Q3 2022
|
DG
Dollar General Corporation
|
Buy |
+1,316,194
|
Page 1 of 3